Brought to you by 
Biosearch Italia reacquires IntraBiotics's ramoplanin rights
01 Aug 2002
Executive Summary
In the US and Canada, Biosearch Italia (peptide-based antibiotics) has licensed its ramoplanin antimicrobial for the prevention and treatment of infectious diseases to IntraBiotics Pharmaceuticals (antibacterial and antifungal pharmaceuticals).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Biosearch Italia reacquires IntraBiotics's ramoplanin rights
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice